Stocksigma LogoStocksigma Logo

Manorama Industries Approves Subsidiary Capital Infusions and Board Appointments

Manorama Industries' board approved capital infusions totaling up to ₹75 crore across six wholly owned overseas subsidiaries on 4th Sep'26

Manorama Industries Approves Subsidiary Capital Infusions and Board Appointments

Manorama Industries Ltd · Outcome · 05 Sept 2026, 1:51 am

Manorama Industries Approves Subsidiary Capital Infusions and Board Appointments Manorama Industries' board approved capital infusions totaling up to ₹75 crore across six wholly owned overseas subsidiaries on 4th Sep'26. Allocations include up to ₹20 crore for Ghana, ₹15 crore each for Burkina Faso and Brazil, ₹10 crore each for Nigeria and Chad, and ₹5 crore for UAE to fund working capital and operations. Additionally, the board appointed Dr. Rohini Tiwari as Non-Executive Independent Director for five years effective 4th Sep'26, while noting the tenure completion of Independent Director Mr. Mudit Kumar Singh on 5th Sep'26.

Original exchange filing (PDF)

More announcements from Manorama Industries Ltd

All Manorama Industries Ltd announcements